This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Johnson & Johnson
Q32020
10/13/2020
Operator
Conference Operator
Good morning and welcome to Johnson & Johnson's Third Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode until the question and answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. If you experience technical difficulties during the conference, you may press star zero to reach the operator. I would now like to turn the conference call over to Johnson & Johnson. You may begin.
Chris DeLorphis
Vice President of Investor Relations
Good morning. This is Chris DeLorphis, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the third quarter of 2020. I hope everyone is healthy and continues to remain safe during these times. Joining me on today's call is Joe Wolk, Executive Vice President and Chief Financial Officer. During the Q&A portion of the call, we will be joined by Jennifer Talbert, Executive Vice President and Worldwide Chairman, Pharmaceuticals. Ashley McAvoy, Executive Vice President and Worldwide Chairman, Medical Devices.
Advertisement
Advertisement
After saving with customized car insurance from Liberty Mutual, I customize everything. Like Marco's backpack.
You're reading a preview of the JNJ Q3 2020 earnings call.
Free account.
Disclaimer